Back to Grants
FEDERAL

Enhancing Mechanistic Research on Precision Probiotic Therapies (R33 Clinical Trial Optional)

This grant funds research on precision probiotic therapies to enhance mechanistic understanding.

About this program

The Enhancing Mechanistic Research on Precision Probiotic Therapies grant supports innovative research aimed at understanding the mechanisms behind probiotic therapies. This funding opportunity is designed for researchers and institutions focused on advancing the field of microbiome research and its applications in health and disease. By providing financial resources, the grant encourages the development of novel probiotic interventions that can be tailored to individual patient needs, ultimately improving health outcomes. Eligible applicants include academic institutions, nonprofit organizations, and other research entities that are engaged in clinical trials or mechanistic studies related to probiotics. The grant aims to foster collaboration among researchers and promote the translation of scientific discoveries into practical therapeutic solutions. Successful proposals will demonstrate a clear research plan, innovative methodologies, and the potential for significant impact in the field of precision medicine.

Eligibility

Academic institutions, nonprofit organizations, and research entities engaged in clinical trials or mechanistic studies.